Overview Extension Study of NS-089/NCNP-02 in DMD Status: Active, not recruiting Trial end date: 2023-07-31 Target enrollment: Participant gender: Summary This is the extension study of NS-089/NCNP-02 (Study NCNP/DMT02), which is designed to assess the safety, tolerability and efficacy of NS-089/NCNP-02 in patients with Duchenne muscular dystrophy (DMD). Phase: Phase 2 Details Lead Sponsor: Nippon Shinyaku Co., Ltd.